Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03204305 · ClinicalTrials.gov registry record · Early Phase 1
Brain Imaging of Cannabinoid Receptors
A Early Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 28
- Enrollment target
NCT03204305: Completed Early Phase 1 study, sponsored by Johns Hopkins University.
NCT03204305 is a Early Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03204305, a Early Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
All participants will be healthy volunteers and all procedures will be completed for research purposes only. Two groups will be recruited, females who use cannabis (marijuana, MJ), and female who do not use cannabis (controls). Female MJ users will be enrolled in a protocol that includes an outpatient drug administration session and a 4-day/3-night inpatient stay on the Johns Hopkins Bayview Clinical Research Unit (CRU). During outpatient visits, MJ users will have an MRI, and complete MJ self-administration and cognitive performance sessions. MJ users will then reside on the CRU,and complete MJ abstinence, and self-report instruments for withdrawal discomfort. A positron emission tomography (PET) scan of brain cannabinoid type 1 receptors will also be completed. Non-users will complete MRI, PET imaging and cognitive testing under an outpatient protocol (no MJ administration).
Interventions
- DRUG Cannabis
- DRUG 11C-OMAR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2017-09-14 |
| Est. Completion | 2020-03-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03204305
The ClinicalTrials.gov registry entry for NCT03204305 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cannabis is the first listed.
NCT03204305 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03204305 about?
NCT03204305 is a clinical study titled "Brain Imaging of Cannabinoid Receptors". All participants will be healthy volunteers and all procedures will be completed for research purposes only. Two groups will be recruited, females who use cannabis (marijuana, MJ), and female who do not use cannabis (controls). Female MJ users will be enrolled in a protocol that includes an outpatie...
What is the current status of trial NCT03204305?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 28 participants. The study started on 2017-09-14. Estimated completion is 2020-03-31.
What interventions are being tested in trial NCT03204305?
The interventions under investigation include: Cannabis (DRUG), 11C-OMAR (DRUG).
Who is sponsoring clinical trial NCT03204305?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.